Cargando…
Ferrous iron content of intravenous iron formulations
The observed biological differences in safety and efficacy of intravenous (IV) iron formulations are attributable to physicochemical differences. In addition to differences in carbohydrate shell, polarographic signatures due to ferric iron [Fe(III)] and ferrous iron [Fe(II)] differ among IV iron for...
Autores principales: | Gupta, Ajay, Pratt, Raymond D., Crumbliss, Alvin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879161/ https://www.ncbi.nlm.nih.gov/pubmed/26956439 http://dx.doi.org/10.1007/s10534-016-9923-7 |
Ejemplares similares
-
Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview
por: Santiago, Palacios
Publicado: (2012) -
Iron infusion and newer intravenous iron formulations
por: Aung, Tim, et al.
Publicado: (2021) -
Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia
por: Chavan, Suyash, et al.
Publicado: (2021) -
Use of ferrous iron by metallo-β-lactamases
por: Cahill, Samuel T., et al.
Publicado: (2016) -
Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers
por: Pratt, Raymond D., et al.
Publicado: (2016)